CNS Tumours Flashcards
Know the major types of CNS tumours Know how to grade CNS tumours Know the major risk factors and genetic predisposition for CNS tumours Know the existing treatments and treatment resistance Understand the major imaging modalities
How common are CNS tumours?
CNS tumours are the 16th most common tumours, making up 2% of all malignancies
Which genetic conditions increase the risk of CNS tumours?
Neurofibromatosis types I and II
What is the relationship between mobile phone use and CNS tumours?
There is a very weak link due to the heat generated by the mobile phone in close proximity to the brain. The further away from the head the phone is used, the less the risk
Which age group are meningiomas most common in?
The elderly
Which age group are benign astrocytomas most common in?
Children
How common are CNS tumours in children?
They are the second most common malignancy after leukaemias and lymphomas
Name some symptoms of CNS tumours in children
Seizures, headache, weakness, clumsiness, difficulty walking, fever, staring, persistent projectile vomiting with no obvious cause, squint, neck tilt, precocious puberty, growth retardation, vision problems, and irritability
What are the red-flag symptoms for a headache caused by a space-occupying lesion, including a tumour?
Chronicity, no improvement with painkillers, worse at night and when lying down, pulsating nature, and a bifrontal, back of head, or throughout head location
Which imaging modality shows fluid and oedema in the brain?
MRI (FLAIR)
Why is MR spectroscopy useful in suspected CNS tumours?
It can identify biochemical markers for inflammation, normal brain, a slow-growing tumour, or an aggressive tumour. A marker for healthy brain is N-acetyl aspartase, found in neurons
Name the three main neurosurgical interventions for CNS tumours
Stereotactic biopsy, open biopsy, and craniotomy and debulking
Where do CNS tumours like to spread?
Along white matter tracts. CNS tumours rarely spread outside of the CNS
Define the grading of CNS tumours
Grade I - benign
Grade II - relatively benign, often slow growing, but will eventually develop into grade III. Typically curable with aggressive resection
Grade III - relatively malignant, almost as aggressive as grade IV, death typically within 5 years
Grade IV - malignant, death typically within a year
Name a genomic marker of glioma aggressiveness
ATRX loss with a TP53 mutation
Name a genomic marker of oligodendrogliomas which are less aggressive
1p/19q co-deletion
Name the four types of glioma
Astrocytomas, oligodendrogliomas, ependymomas, and mixed gliomas